| Title |
Better drugs for Lyme disease: focus on the spirochete
|
|---|---|
| Published in |
Infection and Drug Resistance, September 2018
|
| DOI | 10.2147/idr.s176831 |
| Pubmed ID | |
| Authors |
Raphael B Stricker, Marianne J Middelveen |
| Abstract |
Twenty-five years ago, the AIDS epidemic was wreaking havoc around the world. Although "HIV denialists" threatened to undermine research efforts to combat the epidemic, development of targeted antiviral therapy eventually provided effective treatment for the disease. Now the Lyme disease epidemic is wreaking havoc around the world, and "Lyme denialists" are undermining efforts to combat the epidemic. Drawing on our experience with the AIDS epidemic, there is a significant need to develop targeted therapy to control the Lyme disease epidemic. |
X Demographics
The data shown below were collected from the profiles of 94 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 32 | 34% |
| United Kingdom | 11 | 12% |
| Canada | 7 | 7% |
| Mexico | 2 | 2% |
| Georgia | 1 | 1% |
| France | 1 | 1% |
| Burkina Faso | 1 | 1% |
| Ireland | 1 | 1% |
| Germany | 1 | 1% |
| Other | 0 | 0% |
| Unknown | 37 | 39% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 84 | 89% |
| Practitioners (doctors, other healthcare professionals) | 5 | 5% |
| Science communicators (journalists, bloggers, editors) | 4 | 4% |
| Scientists | 1 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 21 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 5 | 24% |
| Student > Ph. D. Student | 3 | 14% |
| Other | 2 | 10% |
| Professor > Associate Professor | 2 | 10% |
| Student > Master | 2 | 10% |
| Other | 3 | 14% |
| Unknown | 4 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 4 | 19% |
| Immunology and Microbiology | 4 | 19% |
| Biochemistry, Genetics and Molecular Biology | 3 | 14% |
| Veterinary Science and Veterinary Medicine | 2 | 10% |
| Arts and Humanities | 1 | 5% |
| Other | 2 | 10% |
| Unknown | 5 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 72. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 April 2019.
All research outputs
#583,329
of 25,217,627 outputs
Outputs from Infection and Drug Resistance
#25
of 2,024 outputs
Outputs of similar age
#12,562
of 341,725 outputs
Outputs of similar age from Infection and Drug Resistance
#4
of 80 outputs
Altmetric has tracked 25,217,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,024 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 341,725 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.